For Immediate Release
Oak Brook, IL (USA) — The first SLAS Technology issue of 2020, “Flexible Analytical Devices for Point-of-Care Testing,” features a series of articles and research reviews highlighting the ever-increasing popularity of wearable technology devices as they apply to disease detection and health monitoring. Special issue editors Hideaki Tsutsui, Ph.D., (University of California Riverside) and Peter Lillehoj, Ph.D., (Michigan State University) selected eight articles focused on recent technological advances, challenges and the future direction of these devices as they apply to medicine.
Over the last decade, flexible analytical devices have received considerable attention in both academia and industry as they are well-suited for many diagnostic applications, including wearable and in vivo sensing, and point-of-care testing. Plus, compared to conventional analytical devices which are generally made from rigid materials, flexible devices offer unique advantages, such as simplified fabrication, lower costs, enhanced portability and disposability and compliance to curved or deforming surfaces.
This special issue showcases comprehensive reviews and original research on topics ranging from wearable sensors for human motion monitoring and disease diagnosis, flexible electrochemical sensor arrays for human cell culture monitoring, paper-based sensors and immunoassays for diagnostic testing, a paper-based biological solar cell for power generation and storage and a 3D printing strategy for rapid prototyping of flexible microfluidic devices.
Articles and reviews include:
Access to this special issue is available at https://journals.sagepub.com/toc/jlad/25/1 through February 20. For more information about SLAS and its journals, visit www.slas.org/publications/slas-technology/.
SLAS (Society for Laboratory Automation and Screening) is an international community of 16,000 professionals and students dedicated to life sciences discovery and technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.
SLAS Discovery: Advancing the Science of Drug Discovery, 2018 Impact Factor 2.192. Editor-in-Chief Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA).
SLAS Technology: Translating Life Sciences Innovation, 2018 Impact Factor 2.048. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore).
Director of Marketing Communications
Telephone: +1.630.256.7527, ext. 103